Literature DB >> 24094544

Adult eczema prevalence and associations with asthma and other health and demographic factors: a US population-based study.

Jonathan I Silverberg1, Jon M Hanifin.   

Abstract

BACKGROUND: Little is known about the epidemiology of eczema in adults. The goal of this study was to determine the prevalence of and associations with adult eczema in the United States.
METHODS: We used the 2010 National Health Interview Survey from a nationally representative sample of 27,157 adults age 18 to 85 years.
RESULTS: Overall, the 1-year prevalence of eczema was 10.2% (95% CI, 9.7% to 10.6%). The 1-year prevalence of eczema with asthma and/or hay fever was 3.2% (95% CI, 2.8% to 3.3%). Adult eczema was associated with higher prevalence of asthma (P < .001, Rao-Scott χ(2) test), more asthma attacks in the past year (P < .001), and more persistent asthma (P = .02). In multivariate models eczema prevalence was significantly higher in older participants; female subjects; those with Hispanic ethnicity, US birthplace, and higher level of household education; and those currently working (all P ≤ .02, logistic regression).
CONCLUSIONS: This study provides US population-based estimates of eczema prevalence and asthma associations in adults. The results suggest multiple demographic and socioeconomic influences on the US prevalence of adult eczema.
Copyright © 2013 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.

Entities:  

Keywords:  AD; Atopic dermatitis; EAH; Eczema; Eczema with asthma and/or hay fever; Hispanic; NHIS; National Health Interview Survey; age; asthma; atopic dermatitis; atopic disease; birthplace; dermatitis; ethnicity; hay fever; race; rhinoconjunctivitis; socioeconomic status

Mesh:

Year:  2013        PMID: 24094544     DOI: 10.1016/j.jaci.2013.08.031

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  121 in total

1.  IgE antibodies and urinary trimethylarsine oxide accounted for 1-7% population attributable risks for eczema in adults: USA NHANES 2005-2006.

Authors:  Ivy Shiue
Journal:  Environ Sci Pollut Res Int       Date:  2015-08-02       Impact factor: 4.223

2.  Prevalence of Atopic Eczema Among Patients Seen in Primary Care: Data From The Health Improvement Network.

Authors:  Katrina Abuabara; Alexa Magyari; Charles E McCulloch; Eleni Linos; David J Margolis; Sinéad M Langan
Journal:  Ann Intern Med       Date:  2018-12-04       Impact factor: 25.391

Review 3.  The Role and Diagnosis of Allergic Contact Dermatitis in Patients with Atopic Dermatitis.

Authors:  Joshua L Owen; Paras P Vakharia; Jonathan I Silverberg
Journal:  Am J Clin Dermatol       Date:  2018-06       Impact factor: 7.403

4.  Skin barrier defects in atopic dermatitis.

Authors:  Rachana Agrawal; Judith A Woodfolk
Journal:  Curr Allergy Asthma Rep       Date:  2014-05       Impact factor: 4.806

5.  Phenotypical Differences of Childhood- and Adult-Onset Atopic Dermatitis.

Authors:  Jonathan I Silverberg; Paras P Vakharia; Rishi Chopra; Ryan Sacotte; Neha Patel; Supriya Immaneni; Takeisha White; Robert Kantor; Derek Y Hsu
Journal:  J Allergy Clin Immunol Pract       Date:  2017-11-10

6.  Association between atopic dermatitis and serious cutaneous, multiorgan and systemic infections in US adults.

Authors:  Shanthi Narla; Jonathan I Silverberg
Journal:  Ann Allergy Asthma Immunol       Date:  2018-01       Impact factor: 6.347

7.  Associations of childhood eczema severity: a US population-based study.

Authors:  Jonathan I Silverberg; Eric L Simpson
Journal:  Dermatitis       Date:  2014 May-Jun       Impact factor: 4.845

8.  Do children really outgrow their eczema, or is there more than one eczema?

Authors:  Katrina Abuabara; David J Margolis
Journal:  J Allergy Clin Immunol       Date:  2013-10-04       Impact factor: 10.793

9.  Allergies and the Subsequent Risk of Cancer among Elderly Adults in the United States.

Authors:  Monica D'Arcy; Donna R Rivera; Andrew Grothen; Eric A Engels
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-01-30       Impact factor: 4.254

10.  PAR2 Pepducin-Based Suppression of Inflammation and Itch in Atopic Dermatitis Models.

Authors:  Travis P Barr; Chris Garzia; Srijoy Guha; Elizabeth K Fletcher; Nga Nguyen; Adam J Wieschhaus; Lluis Ferrer; Lidija Covic; Athan Kuliopulos
Journal:  J Invest Dermatol       Date:  2018-10-01       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.